Publications BPE group
Journal Article (11)
1.
Journal Article
354, 128769 (2025)
Streamlining the purification of a clinical-grade oncolytic virus for therapeutic applications. Separation and Purification Technology 2.
Journal Article
25 (5), e70022 (2025)
Process Intensification for Recombinant Marburg Virus Glycoprotein Production UsingDrosophilaS2 Cells. Engineering in Life Sciences 3.
Journal Article
13, 134 (2025)
Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomes. Microbiome 4.
Journal Article
109, 74 (2025)
Quantification of intracellular influenza A virus protein dynamics in different host cells after seed virus adaptation. Applied Microbiology and Biotechnology 5.
Journal Article
102 (2), pp. 401 - 412 (2025)
Medium engineering of lipase‐catalyzed reaction usingCO2. Journal of the American Oil Chemists' Society 6.
Journal Article
Mini-review: Application of nanoparticles in plant biotechnology and agriculture. In Vitro Cellular & Developmental Biology - Plant (2025)
7.
Journal Article
4 (3), e70031 (2025)
The microbiologist's guide to metaproteomics. iMeta 8.
Journal Article
318, 105455 (2025)
Fecal metaproteomics enables functional characterization of remission in patients with inflammatory bowel disease. Journal of Proteomics 9.
Journal Article
25 (4), e70027 (2025)
Influenza A Virus Production Following Quality by Design Principles. Engineering in Life Sciences 10.
Journal Article
13 (5), 1286 (2025)
Seed Train Intensification and TFDF-Based Perfusion for MDCK Cell-Based Influenza A Virus Production. Processes 11.
Journal Article
New Avenues for Human Blood Plasma Biomarker Discovery via Improved In-Depth Analysis of the Low-Abundant N-glycoproteome. Engineering (2025)
Talk (3)
12.
Talk
Influenza Vector-Based Defective Interfering Particles for Use as Broad-Spectrum Antiviral and Mucosal Live Vaccine: Construction, Production and in Vivo Efficacy. 34th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)
13.
Talk
Engineered influenza vectors for use as broadly-acting antivirals and live nasal vaccines: design, manufacture and in vivo efficacy. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
14.
Talk
Expanding Glycoproteomics: Including N-Glycopeptides Bearing Glucuronidated, O-Acetylated or Sulfated N-Glycans in the Analysis of Human Serum Proteins such as Immunoglobulin A. GlycoBioTec 2025, Berlin (Germany) (2025)
Poster (7)
15.
Poster
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
16.
Poster
Production of Oncolytic Newcastle Disease Virus in EB66 cells: Characterization of Parameters for Process Intensification. Cell Culture Engineering (CCE) XIX, Tucson Arizona (USA) (2025)
17.
Poster
Quantification of intracellular influenza A virus proteins shows changes in dynamics related to host cell line and virus seed. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
18.
Poster
Genetically engineered influenza defective interfering particles with enhanced immune activation potential and antiviral efficacy in vitro. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
19.
Poster
Molecular basis for the antiviral activity of the influenza defective interfering particle “OP7”. 34th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)
20.
Poster
The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 34th Annual Meeting of the Society for Virology, Hamburg (Germany) (2025)
21.
Poster
The secrets of “OP7”, an influenza DIP: mathematical model, impact of mutations and antiviral mechanisms. 9th European Congress of Virology (ECV), Cavtat/Dubrovnik (Croatia) (2025)
Thesis - PhD (3)
22.
Thesis - PhD
In-Depth N-Glycan Analysis Using a Synergy of Glycomics Technologies: Method Development and Biomedical Applications. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2025)
23.
Thesis - PhD
Modeling the Dynamics of Cell Growth, Central Carbon Metabolism and Virus Production in Animal Cells. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2025)
24.
Thesis - PhD
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. Dissertation, Otto-von-Guericke-Universität, Magdeburg (2025)